The effect of medical glue on bleeding after intravenous line insertion in babies: a clinical trial.

The effect of cyanoacrylate glue on bleeding after peripherally inserted central catheter insertion in neonates: a randomised controlled trial.

Status

Not yet recruiting

Phases

Unknown

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12621001717842

Enrollment

Registered

2021-12-16

Start date

2022-01-31

Completion date

Unknown

Last updated

2021-12-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Babies in intensive care nurseries often have long-term lines inserted into their veins. The insertion site can continue ooze blood and affect the integrity of the dressing. We are studying whether using medical glue when the line is inserted can reduce the rate of bleeding afterwards. Glue may also be able to reduce the rate of lines accidentally coming out, as well as helping prevent babies from developing line-related infections.

Interventions

Routine PICC line insertion (sterile technique, chlorhexidine skin preparation, insertion of 24G/28G PICC via introducer needle/cannula, confirmation of correct placement with contrast-enhanced x-ray) and standard adhesive dressings applied (Steristrips and Tegaderm). Addition of 0.15mL of cyanoacrylate glue applied to the insertion point via SecurePortIV applicator device. Intervention performed by a neonatal clinician once only, taking approximately 30 minutes.

Study design

Allocation

Randomised controlled trial

Intervention model

Parallel

Primary purpose

Treatment

Masking

Blinded (masking used) (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender

All

Age

No minimum to 3 Months

Healthy volunteers

Inclusion criteria

Any neonates requiring PICC line insertion will be considered. There is no specific age requirement, any baby admitted to the neonatal intensive care nursery can be considered.

Exclusion criteria

Neonates with a history of adverse skin reactions with dressings/adhesives would be excluded, as well as in those whose parent/s are unable to give informed consent.

Outcome results